WebJan 30, 2024 · Esmolol is a valuable emergency medication for focal atrial tachycardia, particularly in individuals experiencing active bronchospasm. Furthermore, esmolol has proven to be a safe and efficient medication for controlling blood pressure during surgery due to its short half-life.
DA:81PA:16MOZ Rank:10
Esmolol Dosage Guide + Max Dose, Adjustments - Drugs.com
WebDec 12, 2023 · Detailed Esmolol dosage information for adults. Includes dosages for Atrial Fibrillation, Supraventricular Tachycardia, Atrial Flutter and more; plus renal, liver and dialysis adjustments.
WebDec 12, 2023 · What is esmolol? Esmolol is used to help keep the heart beating normally in people with certain heart rhythm disorders, such as atrial fibrillation or atrial flutter. Esmolol is also used during surgery to help regulate blood pressure and heart rate. Esmolol may also be used for purposes not listed in this medication guide.
WebDescriptions. Esmolol is used to control rapid heartbeats or abnormal heart rhythms. This medicine is also used to treat fast heartbeat and high blood pressure during surgery, after surgery, or during other medical procedures . …
DA:91PA:89MOZ Rank:77
Esmolol | Treatment & Management | Point of Care - StatPearls
WebJan 30, 2024 · Point of Care - Clinical decision support for Esmolol. Treatment and management. Indications, Mechanism of Action, Administration, Adverse Effects, Contraindications, Monitoring, Toxicity, Enhancing Healthcare Team Outcomes.
DA:2PA:67MOZ Rank:86
Esmolol: Uses, Interactions, Mechanism of Action | DrugBank Online
WebEsmolol is a cardioselective beta-adrenergic blocker used for the short-term control of ventricular rate and heart rate in various types of tachycardia, including perioperative tachycardia and hypertension. Brand Names. Brevibloc. Generic Name. Esmolol. DrugBank Accession Number. DB00187. Background.
DA:98PA:79MOZ Rank:98
Managing Critically ill Patients with Esmolol - CHEST
WebEsmolol is a new intravenous β-adrenergic blocker with an ultrashort (nine-minute) elimination half-life, which has been studied predominantly for control of supraventricular tachycardia and management of certain types of hypertension.
WebESMOLOL HCL (Brevibloc) 2.5 gm in 250 ml 0.9% NaCl (10mg/ml) Su raventicular tach cardia S Initial dose 250 to 500 mcg/kg undiluted IV push over 1 minute followed by maintenance infusion (50 mcg/kg/min for 4 mins). May repeat same IV push and increase infusion to 100 mc 1k Imin Peri-o rative tach cardia and/or h ertension Initial dose